Evaluation of Restory - an Online Trauma Treatment for Victims of Sexual Abuse
Key facts
- Who runs it
- Karolinska Institutet
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 140 people, planned
- Started
- 4 May 2026
- Expected to end
- 4 Nov 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Restory
- Record updated
- 7 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- 18+ years
- exposure to sexual violence where a minimum of 1 month has passed since the incident
- self-reported total PCL-5 of minimum 30
- current stable dose of psychotropic medication (for at least 4 weeks) or medication free
- sufficient Swedish skills
- willingness and availability to participate
Who cannot take part
- current participation in other trauma-focused CBT or Eye Movement Desensitization and Reprocessing therapy
- severe psychiatric illness requiring immediate alternative treatment (such as high acute suicide risk or presence of psychotic episode, assessed during screening interview)
- Ongoing trauma-related threat (e.g. living with a violent spouse)
- current benzodiazepine treatment
- no trauma memory
This trial is currently available in Sweden.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This project aims to evaluate Restory - a newly developed anonymous, iCBT prolonged exposure therapy program specifically tailored for victims of sexual abuse - using a pre-registered randomized controlled trial with waitlist control. The primary research question is whether Restory is more effective than a waitlist control in reducing PTSD symptom severity score, as measured by PCL-5.
The 2 groups in the trial
- RestoryTreatment being tested
A free, anonymous, internet-delivered prolonged exposure therapy program specifically tailored for victims of sexual abuse
- WaitlistNo study treatment, for comparison
The waitlist control group will wait a minimum of nine weeks before starting active treatment (Restory). During the waitlist period, the participant will be followed up, responding to the same set of questionnaires as participants in the treatment group.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomised Waitlist Controlled Clinical Trial of the Restory Trauma Treatment Program
- Record updated
- 7 August 2026